The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Leptin in Leanness and Obesity
Open accessAbstract
Leptin has emerged over the past 2 decades as a key hormone secreted by adipose tissue that conveys information on energy stores. Leptin is considered an important regulator of both neuroendocrine function and energy homeostasis. Numerous studies (mainly precLinicaL and much less in humans) have investigated the mechanisms of leptin’s actions both in the healthy state as well as in a wide range of metabolic diseases. In this review, the authors present leptin physiology and review the main findings from animal studies, observational and interventional studies, and clinical trials in humans that have investigated the role of leptin in metabolism and cardiometabolic diseases (energy deficiency, obesity, diabetes, cardiovascular diseases, nonalcoholic fatty liver disease). The authors discuss the similarities and discrepancies between animal and human biology and present clinical applications of leptin, directions for future research, and current approaches for the development of the next-generation leptin analogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
Anatomy and regulation of the central melanocortin system
Cone, R. D. (2005) · Nature Neuroscience · doi:10.1038/nn1455 · Cited by 1,583
Leptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247
Caro, J. F., Kolaczynski, J. W., Nyce, M. R., Ohannesian, J. P., Opentanova, I., Goldman, W. H., Lynn, R. B., Zhang, P.-L., Sinha, M. K., & Considine, R. V. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03173-x · Cited by 1,175
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215693 · Cited by 1,105
Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.
Halaas, J. L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D. A., & Friedman, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8878 · Cited by 1,033
Research works printed but not linked: 101
- Boden, 1996, Effect of fasting on serum leptin in normal human subjects, J Clin Endocrinol Metab, 81, 3419
- Farr, 2015, Leptin and the brain: influences on brain development, cognitive functioning and psychiatric disorders, Metabolism, 64, 114, 10.1016/j.metabol.2014.07.004 · DOI
- Banks, 1996, Leptin enters the brain by a saturable system independent of insulin, Peptides, 17, 305, 10.1016/0196-9781(96)00025-3 · DOI · Paper page
- Faouzi, 2007, Differential accessibility of circulating leptin to individual hypothalamic sites, Endocrinology, 148, 5414, 10.1210/en.2007-0655 · DOI · Paper page
- Frank, 2011, Leptin therapy in a congenital leptin-deficient patient leads to acute and long-term changes in homeostatic, reward, and food-related brain areas, J Clin Endocrinol Metab, 96, E1283, 10.1210/jc.2010-2713 · DOI
- Farr, 2014, Leptin therapy alters appetite and neural responses to food stimuli in brain areas of leptin-sensitive subjects without altering brain structure, J Clin Endocrinol Metab, 99, E2529, 10.1210/jc.2014-2774 · DOI
- Hinkle, 2013, Effects of reduced weight maintenance and leptin repletion on functional connectivity of the hypothalamus in obese humans, PLoS One, 8, 10.1371/journal.pone.0059114 · DOI
- Chou, 2011, Leptin is an effective treatment for hypothalamic amenorrhea, Proc Natl Acad Sci U S A, 108, 6585, 10.1073/pnas.1015674108 · DOI · Paper page
- Bouzoni, 2020, Circulating profile of activin-follistatin-inhibin axis in women with hypothalamic amenorrhea in response to leptin treatment, Metabolism, 154392, 10.1016/j.metabol.2020.154392 · DOI
- Licinio, 2004, Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults, Proc Natl Acad Sci U S A, 101, 4531, 10.1073/pnas.0308767101 · DOI · Paper page
- Quennell, 2009, Leptin indirectly regulates gonadotropin-releasing hormone neuronal function, Endocrinology, 150, 2805, 10.1210/en.2008-1693 · DOI · Paper page
- Carro, 1997, Regulation of in vivo growth hormone secretion by leptin, Endocrinology, 138, 2203, 10.1210/endo.138.5.5238 · doi:10.1210/endo.138.5.5238 · Paper page
- Chan, 2006, Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans, Proc Natl Acad Sci U S A, 103, 8481, 10.1073/pnas.0505429103 · DOI · Paper page
- Pilitsi, 2019, Metabolism, 97, 32, 10.1016/j.metabol.2019.05.004 · DOI
- Dardeno, 2010, Leptin in human physiology and therapeutics, Front Neuroendocrinol, 31, 377, 10.1016/j.yfrne.2010.06.002 · DOI · Paper page
- van der Kroon, 1982, Congenital hypothyroidism in latent obese (ob/ob) mice, Int J Obes, 6, 83
- Chrysafi, 2020, Leptin alters energy intake and fat mass but not energy expenditure in lean subjects, Nat Commun, 11, 5145, 10.1038/s41467-020-18885-9 · DOI · Paper page
- Matarese, 2013, Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia, Proc Natl Acad Sci U S A, 110, E818, 10.1073/pnas.1214554110 · DOI
- Zhang, 1994, Positional cloning of the mouse obese gene and its human homologue, Nature, 372, 425, 10.1038/372425a0 · DOI · Paper page
- Lindstrom, 2007, The physiology of obese-hyperglycemic mice [ob/ob mice], ScientificWorldJournal, 7, 666, 10.1100/tsw.2007.117 · DOI · Paper page
- Cohen, 2001, Selective deletion of leptin receptor in neurons leads to obesity, J Clin Invest, 108, 1113, 10.1172/JCI200113914 · DOI
- Singh, 2009, Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels, Proc Natl Acad Sci U S A, 106, 13100, 10.1073/pnas.0903723106 · DOI
- Halaas, 1995, Weight-reducing effects of the plasma protein encoded by the obese gene, Science, 269, 543, 10.1126/science.7624777 · DOI · Paper page
- Weigle, 1995, Recombinant ob protein reduces feeding and body weight in the ob/ob mouse, J Clin Invest, 96, 2065, 10.1172/JCI118254 · DOI · Paper page
- Sloan, 2011, Central leptin signaling is required to normalize myocardial fatty acid oxidation rates in caloric-restricted ob/ob mice, Diabetes, 60, 1424, 10.2337/db10-1106 · DOI
- Erickson, 1996, Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y, Science, 274, 1704, 10.1126/science.274.5293.1704 · DOI · Paper page
- Vaisse, 1996, Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice, Nat Genet, 14, 95, 10.1038/ng0996-95 · DOI · Paper page
- Carpino, 2005, Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation, Dig Liver Dis, 37, 349, 10.1016/j.dld.2004.11.009 · DOI · Paper page
- Hwa, 1997, Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice, Am J Physiol, 272, R1204
- Commins, 1999, Induction of uncoupling protein expression in brown and white adipose tissue by leptin, Endocrinology, 140, 292, 10.1210/endo.140.1.6399 · DOI · Paper page
- Ukropec, 2006, Leptin is required for uncoupling protein-1-independent thermogenesis during cold stress, Endocrinology, 147, 2468, 10.1210/en.2005-1216 · DOI
- Beltowski, 2006, Leptin and atherosclerosis, Atherosclerosis, 189, 47, 10.1016/j.atherosclerosis.2006.03.003 · DOI · Paper page
- Konstantinides, 2001, Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity, J Clin Invest, 108, 1533, 10.1172/JCI13143 · DOI · Paper page
- Simonds, 2017, Does leptin cause an increase in blood pressure in animals and humans?, Curr Opin Nephrol Hypertens, 26, 20, 10.1097/MNH.0000000000000287 · DOI
- Masuzaki, 1995, Augmented expression of the obese gene in the adipose tissue from rats fed high-fat diet, Biochem Biophys Res Commun, 216, 355, 10.1006/bbrc.1995.2631 · DOI
- Cusin, 1996, The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals, Diabetes, 45, 1446, 10.2337/diab.45.10.1446 · DOI · Paper page
- Lu, 1994, Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor, Nature, 371, 799, 10.1038/371799a0 · DOI · Paper page
- Aizawa-Abe, 2000, Pathophysiological role of leptin in obesity-related hypertension, J Clin Invest, 105, 1243, 10.1172/JCI8341 · DOI · Paper page
- Simonds, 2014, Leptin mediates the increase in blood pressure associated with obesity, Cell, 159, 1404, 10.1016/j.cell.2014.10.058 · DOI · Paper page
- Harrison, 2019, Fluorescent blood-brain barrier tracing shows intact leptin transport in obese mice, Int J Obes (Lond), 43, 1305, 10.1038/s41366-018-0221-z · DOI
- Kleinert, 2018, Time-resolved hypothalamic open flow micro-perfusion reveals normal leptin transport across the blood-brain barrier in leptin resistant mice, Mol Metab, 13, 77, 10.1016/j.molmet.2018.04.008 · DOI
- Farr, 2016, Central nervous system regulation of eating: Insights from human brain imaging, Metabolism, 65, 699, 10.1016/j.metabol.2016.02.002 · DOI · Paper page
- Herz, 2019, Adipose tissue browning in mice and humans, J Endocrinol, 241, R97, 10.1530/JOE-18-0598 · DOI
- Considine, 1996, Serum immunoreactive-leptin concentrations in normal-weight and obese humans, N Engl J Med, 334, 292, 10.1056/NEJM199602013340503 · DOI · Paper page
- Marshall, 2000, Percent body fat and lean mass explain the gender difference in leptin: analysis and interpretation of leptin in Hispanic and non-Hispanic white adults, Obes Res, 8, 543, 10.1038/oby.2000.70 · DOI
- Bidulescu, 2020, Associations of leptin and adiponectin with incident type 2 diabetes and interactions among African Americans: the Jackson heart study, BMC Endocr Disord, 20, 31, 10.1186/s12902-020-0511-z · DOI
- Ostlund, 1996, Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates, J Clin Endocrinol Metab, 81, 3909
- Shankar, 2010, Positive relationship between plasma leptin level and hypertension, Hypertension, 56, 623, 10.1161/HYPERTENSIONAHA.109.148213 · DOI
- Ma, 2009, Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute Family Heart Study, Hypertension, 53, 473, 10.1161/HYPERTENSIONAHA.108.118133 · DOI
- Shanker, 2012, Relationship of adiponectin and leptin to coronary artery disease, classical cardiovascular risk factors and atherothrombotic biomarkers in the IARS cohort, Thromb Haemost, 108, 769, 10.1160/TH12-04-0263 · DOI
- Taneli, 2006, Increased serum leptin concentrations in patients with chronic stable angina pectoris and ST-elevated myocardial infarction, Angiology, 57, 267, 10.1177/000331970605700302 · DOI
- Azar, 2006, Percutaneous coronary intervention increases leptin and decreases adiponectin levels, Clin Endocrinol (Oxf), 65, 712, 10.1111/j.1365-2265.2006.02654.x · DOI
- Yang, 2017, Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis, PLoS One, 12
- Hoefle, 2007, Leptin, leptin soluble receptor and coronary atherosclerosis, Eur J Clin Invest, 37, 629, 10.1111/j.1365-2362.2007.01842.x · DOI
- Puurunen, 2017, Leptin predicts short-term major adverse cardiac events in patients with coronary artery disease, Ann Med, 49, 448, 10.1080/07853890.2017.1301678 · DOI
- Martin, 2015, Leptin and incident cardiovascular disease: the Multi-ethnic Study of Atherosclerosis (MESA), Atherosclerosis, 239, 67, 10.1016/j.atherosclerosis.2014.12.033 · DOI
- Seven, 2015, Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study, PLoS One, 10, 10.1371/journal.pone.0128987 · DOI
- Sierra-Johnson, 2007, Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population, Am J Cardiol, 100, 234, 10.1016/j.amjcard.2007.02.088 · DOI
- Wannamethee, 2013, Adiposity, adipokines, and risk of incident stroke in older men, Stroke, 44, 3, 10.1161/STROKEAHA.112.670331 · DOI
- Bevan, 2011, Adiponectin level as a consequence of genetic variation, but not leptin level or leptin: adiponectin ratio, is a risk factor for carotid intima-media thickness, Stroke, 42, 1510, 10.1161/STROKEAHA.110.602375 · DOI
- Saber, 2015, Serum leptin levels and the risk of stroke: the Framingham study, Stroke, 46, 2881, 10.1161/STROKEAHA.115.009463 · DOI
- Katsiki, 2018, Leptin, cardiovascular diseases and type 2 diabetes mellitus, Acta Pharmacol Sin, 39, 1176, 10.1038/aps.2018.40 · DOI · Paper page
- Perakakis, 2020, The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease, Metabolism, 111S, 154320, 10.1016/j.metabol.2020.154320 · DOI · Paper page
- Polyzos, 2020, Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD, J Clin Endocrinol Metab, 105, e399, 10.1210/clinem/dgz172 · DOI
- Polyzos, 2019, Fatty liver in lipodystrophy: a review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement, Metabolism, 96, 66, 10.1016/j.metabol.2019.05.001 · DOI
- Boutari, 2018, Association of adipokines with development and progression of nonalcoholic fatty liver disease, Endocrinol Metab (Seoul), 33, 33, 10.3803/EnM.2018.33.1.33 · DOI · Paper page
- Wong, 2004, Leptin hormonal kinetics in the fed state: effects of adiposity, age, and gender on endogenous leptin production and clearance rates, J Clin Endocrinol Metab, 89, 2672, 10.1210/jc.2003-031931 · DOI
- Chan, 2007, Pharmacokinetics of recombinant methionyl human leptin after subcutaneous administration: variation of concentration-dependent parameters according to assay, J Clin Endocrinol Metab, 92, 2307, 10.1210/jc.2006-2864 · DOI
- Chan, 2008, Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity, Clin Pharmacokinet, 47, 753, 10.2165/00003088-200847110-00006 · DOI
- Sienkiewicz, 2011, Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women, Metabolism, 60, 1211, 10.1016/j.metabol.2011.05.016 · DOI · Paper page
- Addy, 2003, Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy, J Clin Endocrinol Metab, 88, 627, 10.1210/jc.2002-020795 · DOI · Paper page
- Lee, 2006, Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy, J Clin Endocrinol Metab, 91, 2605, 10.1210/jc.2005-1545 · DOI · Paper page
- Tsoukas, 2015, Leptin in congenital and HIV-associated lipodystrophy, Metabolism, 64, 47, 10.1016/j.metabol.2014.07.017 · DOI
- Magkos, 2011, Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study, Metabolism, 60, 1045, 10.1016/j.metabol.2010.10.002 · DOI
- Brown, 2018, Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy, Endocrine, 60, 479, 10.1007/s12020-018-1589-1 · DOI
- Oral, 2019, Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy, Endocrine, 64, 500, 10.1007/s12020-019-01862-8 · DOI
- Brown, 2018, Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy, J Clin Invest, 128, 3504, 10.1172/JCI95476 · DOI
- Lawler, 2020, Leptin-mediated changes in the human metabolome, J Clin Endocrinol Metab, 105, 2541, 10.1210/clinem/dgaa251 · DOI
- Grewal, 2020, Metabolomic analysis of the effects of leptin replacement therapy in patients with lipodystrophy, J Endocr Soc, 4, bvz022, 10.1210/jendso/bvz022 · DOI
- Brown, 2015, Leptin does not mediate hypertension associated with human obesity, Cell, 162, 465, 10.1016/j.cell.2015.07.007 · DOI
- Muniyappa, 2014, Effects of leptin replacement therapy on pancreatic beta-cell function in patients with lipodystrophy, Diabetes Care, 37, 1101, 10.2337/dc13-2040 · DOI
- Oral, 2006, Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy, J Clin Endocrinol Metab, 91, 621, 10.1210/jc.2005-1220 · DOI
- Heymsfield, 1999, Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial, JAMA, 282, 1568, 10.1001/jama.282.16.1568 · DOI · Paper page
- Moon, 2015, Identification and saturable nature of signaling pathways induced by metreleptin in humans: comparative evaluation of in vivo, ex vivo, and in vitro administration, Diabetes, 64, 828, 10.2337/db14-0625 · DOI
- Mittendorfer, 2011, Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes, Diabetes, 60, 1474, 10.2337/db10-1302 · DOI
- Hukshorn, 2002, The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects, Int J Obes Relat Metab Disord, 26, 504, 10.1038/sj.ijo.0801952 · DOI
- Korner, 2013, Randomized double-blind placebo-controlled study of leptin administration after gastric bypass, Obesity (Silver Spring), 21, 951, 10.1002/oby.20433 · DOI · Paper page
- Lejeune, 2003, Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men, Int J Obes Relat Metab Disord, 27, 1494, 10.1038/sj.ijo.0802431 · DOI
- Kissileff, 2012, Leptin reverses declines in satiation in weight-reduced obese humans, Am J Clin Nutr, 95, 309, 10.3945/ajcn.111.012385 · DOI
- Rosenbaum, 2008, Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli, J Clin Invest, 118, 2583
- DePaoli, 2018, Efficacy of metreleptin for weight loss in overweight and obese adults with low leptin levels, Diabetes, 67, 296-LB, 10.2337/db18-296-LB · DOI
- Upadhyay, 2018, Pharmacotherapy of type 2 diabetes: an update, Metabolism, 78, 13, 10.1016/j.metabol.2017.08.010 · DOI · Paper page
- Moon, 2011, Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans, Diabetes Care, 34, 132, 10.2337/dc10-0518 · DOI
- Li, 2015, Hypothalamic amylin acts in concert with leptin to regulate food intake, Cell Metab, 22, 1059, 10.1016/j.cmet.2015.10.012 · DOI
- Ravussin, 2009, Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy, Obesity (Silver Spring), 17, 1736, 10.1038/oby.2009.184 · DOI · Paper page
- Yuan, 2017, Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity, J Control Release, 263, 172, 10.1016/j.jconrel.2017.03.029 · DOI
- Wang, 2018, [D-Leu-4]-OB3 and MA-[D-Leu-4]-OB3, small molecule synthetic peptide leptin mimetics, improve glycemic control in diet-induced obese (DIO) mice, Peptides, 101, 51, 10.1016/j.peptides.2017.12.012 · DOI
- Vauthier, 2017, Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling, Mol Metab, 6, 159, 10.1016/j.molmet.2016.10.009 · DOI
- Digenio, 2018, Antisense inhibition of protein tyrosine phosphatase 1B With IONIS-PTP-1BRx improves insulin sensitivity and reduces weight in overweight patients with type 2 diabetes, Diabetes Care, 41, 807, 10.2337/dc17-2132 · DOI
- Kars, 2010, Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women, Diabetes, 59, 1899, 10.2337/db10-0308 · DOI · Paper page
- von Schnurbein, 2019, Leptin is not essential for obesity-associated hypertension, Obes Facts, 12, 460, 10.1159/000501319 · DOI
Cited by
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Stefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Self-citation
Metadata
- Authors
- Perakakis, N., Farr, O. M., & Mantzoros, C. S.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 77
- Issue
- 6
- Pages
- 745-760
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W3128876677
- Cited by
- 212
- References
- 40
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 380 d)
- Funders
- Deutsche Forschungsgemeinschaft (389891681, PE 2431/3-1:1)
- Novo Nordisk
- National Institutes of Health (K24DK081913)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leptin in Leanness and Obesity. https://app.cochat.ai/papers/10.1016/j.jacc.2020.11.069
- The paper
- Perakakis, N., Farr, O. M., & Mantzoros, C. S. (2021). Leptin in Leanness and Obesity. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2020.11.069
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.